Background/Aims: FBXO6 is the substrate recognition component of a Skp1-Cullin1-F-box protein (SCF) ubiquitin E3 ligase complex, recognizing the chitobiose in unfolded N-glycoprotein to target glycoproteins for polyubiquitination and degradation. Although how FBXO6 recognizes glycoprotein has been fully investigated, the ubiquitination substrates of FBXO6 remain largely unknown. Previously, we have systematically identified the glycoproteins that interact with FBXO6 in an N-glycan dependent manner by LC/MS spectrum and confirmed the interaction between FBXO6 and glycosylated Ero1L, a protein disulfide oxidase in endoplasmic reticulum (ER). Methods: The relationship between endogenous Ero1L and exogenous Flag-FBXO6 were determined by Western blot. In vivo ubiquitination assay was used to detect the direct effect of FBXO6 in the regulation of Ero1L. Both CCK8 and FACS assays were used to determine the apoptosis ratio of cells after treatments. Results: Ero1L is a ubiquitination substrate of FBXO6. FBXO6 mediates the degradation of Ero1L through a ubiquitylation-dependent pathway. Overexpression of FBXO6 increased the polyubiquitination and decreased the stability of Ero1L, whereas inhibition of FBXO6 prolonged the half-life of Ero1L. Functionally, we show that FBXO6 inhibits ER stress-induced apoptosis by modulating the protein level of Ero1L. Conclusion: Collectively, our results demonstrate FBXO6 as a functional E3 ubiquitin ligase for Ero1L that plays a critical role in inhibiting ER stress-induced apoptosis.
FBXO6-Mediated Ubiquitination and Degradation of Ero1L Inhibits Endoplasmic Reticulum Stress-Induced Apoptosis

Introduction
In eukaryotic cells, approximately one-third of proteins are subjected to the secretory pathway and most of which are modified by N-linked oligosaccharides in the endoplasmic reticulum (ER) [1] . In the ER quality control system, improperly folded proteins failed to subject to refolding cycles will be selected for ER-associated degradation (ERAD), which involves transfer of these proteins from the ER to the cytosol followed by recognization and degradation by the ubiquitin−proteasome system [2] . Perturbation of the ER environment, such as increased improperly folded proteins in ER, can cause ER stress and trigger the unfolded protein response (UPR). High levels of misfolded proteins can disrupt cellular homeostasis, induce ER stress, and might eventually lead to apoptosis [3] [4] [5] . Indeed, the accumulation of specific misfolded proteins contributes to the development of disorders of the nervous system, such as Alzheimer's, Huntington's and Parkinson's disease [6] [7] [8] .
Endoplasmic reticulum oxidase 1 (ERO1), an ER-localized protein disulfide isomerase (PDI) oxidase, accepts electrons from reduced PDI and hands them over to molecular oxygen, catalyzing oxygen-mediated disulfide bond formation [9, 10] . ERO1 is conserved in eukaryotes and there are two ERO1 orthologues, Ero1L/Ero1α and Ero1LB/Ero1β, in mammal [11, 12] . It has been shown that C/EBP-homologous protein (CHOP) plays critical roles in ER-stress-induced apoptosis in a number of disease models including diabetes and Parkinson's disease [3, 13] . CHOP triggers calcium-dependent ER stress-induced apoptosis through an Ero1L-inositol 1,4,5-triphosphate (IP3) receptor (IP3R) pathway [14] . Ero1L is a transcriptional target of CHOP that activates the ER calcium-release channel IP3R1 via disulfide bond formation in a lumenal loop of IP3R1 and promotes a hyperoxidizing environment that leads to cell death [11, 14] . However, how to eliminate Ero1L is completely unknown.
FBXO6 is reported to be involved in the ERAD pathway, as either silencing the expression of endogenous FBXO6 or overexpression of the dominant negative form of FBXO6 resulted in inhibition of ERAD substrates degradation [15, 16] . Moreover, inhibition of FBXO6 expression increased cadmium-induced increase in expression of the ER stress marker proteins, BiP and CHOP and enhance cadmium-induced ER stress [17, 18] . However, the direct substrate of FBXO6 involved in this process is completely unknown.
Previously, by using protein purification approach combined with LC−MS, we have identified 29 highly confident glycoproteins that interact with FBXO6 in an N-glycan dependent manner [19] . Ero1L is one of these glycoproteins. In our unbiased screen, among ten F-box proteins, only FBXO6 interacted with glycosylated Ero1L [19] . However, the relationship and functional relevance between Ero1L and FBXO6 were still unclear.
In the present study, we provide the first evidence that Ero1L is a substrate of FBXO6. FBXO6 mediates the ubiquitination and degradation of Ero1L plays a critical role in the regulation of ER stress-induced apoptosis.
Material and Methods
Cell culture and treatments 293T and A549 cells were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). All cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum in a 5% CO2/95% air at 37°C under saturated humidity. Dulbecco's modified Eagle's medium, fetal bovine serum, trypsin, were obtained from Invitrogen (Carlsbad, CA, USA). MLN4924 (HY-10484) was purchased from Medkoo (North Carolina, USA). Puromycin (P9620), MG132 (M8699) and cycloheximide (C1988) were obtained from Sigma (St. Louis, MO, U.S.A).
shRNAs shRNAs against FBXO6 (TRCN0000424635, TRCN0000007733), Ero1L (TRCN0000300619,  TRCN0000300621) and pLKO.1 vector were purchased from Sigma (St. Louis, MO, USA). 
Construction of Stable Cell Lines
The construction of pBabe-3×Flag-FBXO6WT and pBabe-3×Flag-FBXO6Mutant plasmids have been described previously [19] . Viral supernatants were produced in 293T cells co-transfected with the pBabe3×Flag-control or pBabe-3×Flag-FBXO6WT and pBabe-3×Flag-FBXO6Mutant constructs and packaging vectors GAGPOL and VSVG (Clontech, Mountain View, CA, USA). Viral supernatants were collected 48and 72 hours after transfection. For 293T and HeLa cells, viral supernatants were added to the cells with 10 μg/mL ploybrane for 48 hours. Then cells were selected with puromycin (1.5μg/mL) for a week. Positive polyclonal populations were identified by Western blot.
CCK8 assay
HeLa cells were inoculated in a 96-well plate 24 hours before transfection. CCK8 solution was added to each well of the plate 24 hours after transfection. The plate was then incubated for 4 hours in an incubator. The absorbance at 450nm was measured by using a microplate reader (SpectraMax Paradigm, Molecular Devices, USA).
Western Blot
Cells were harvested and lysed with ice-cold lysis buffer (62.5mM Tris-HCl, pH 6.8, 100 mM DTT, 2% w/v SDS, 10% glycerol). After centrifugation at 12000g for 10 min at 4°C, proteins in the supernatants were quantified and separated by 10 % SDS-PAGE transferred to NC membrane (Amersham Bioscience, Buckinghamshire, U.K.). Membranes were blocked by 5% nonfat milk in PBS for 1hour and immunoblotted with antibodies as indicated, followed by HRP-linked secondary antibodies (Ptglab, Wuhan, Hubei, China). 
Apoptosis assays
Annexin V-FITC assay was carried out by Annexin V-FITC Apoptosis Detection Kit according to manufacturer's instruction (BD, San Diego, CA, USA) and has been described previously. Briefly, 3 × 10 5 cells were collected, washed twice with cold PBS, resuspended in binding buffer and incubated with Annexin V-FITC at room temperature, followed by addition of propidium iodide for 5 min. Fluorescent intensities were determined on flow cytometry (Beckman Coulter, Miami, FL, USA).
Statistical analysis
Values were shown as mean ± SD. Statistical differences were determined by a Student t test. Statistical significance is displayed as *p<0.05, **p<0.01 or ***p<0.001.
Results
FBXO6 controls the degradation of Ero1L
The interaction between glycosylated Ero1L and FBXO6 drove us to ask whether FBXO6 is the ubiquitin E3 ligase for Ero1L. To test this possibility, 293T cells were transfected with Flag-FBXO6 plasmids. As depicted in Figure 1A , we could clearly observe the inverse relationship between endogenous Ero1L and exogenous Flag-FBXO6. Interestingly, FBXO6WT but not FBXO6 Mutant, which could not recognize glycoproteins, decreases the proteins level of Ero1L in a dose-dependent manner, which is consistent with our previous observation that FBXO6 Mutant could not interact with Ero1L. Moreover, FBXO6-induced Ero1L degradation could be efficiently reversed by the administration of either proteasome inhibitor MG132 or NEDD8-activating enzyme inhibitor MLN4924 (Fig. 1B) . Furthermore, silencing the expression of FBXO6 by shRNAs in A549 cells significantly increased the protein level of Ero1L (Fig. 1C) . Taken together, these data suggest that FBXO6 controls the degradation of Ero1L. Fig. 2A) . Indeed, overexpression of FBXO6 decreased the stability of Ero1L ( Fig. 2B) , whereas silencing the expression of FBXO6 enhanced the half-life of Ero1L (Fig.  2C) , suggesting that FBXO6-induced Ero1L ubiquitination led to Ero1L degradation.
FBXO6 controls ER stress-induced apoptosis
Ero1L is a transcriptional target of CHOP and plays critical roles in ER-stress-induced apoptosis [14] . FBXO6 regulates the abundance of Ero1L, which leading us to ask whether FBXO6 plays a role in ER stress-induced apoptosis. To this end, A549 cells stably expression control shRNA or shRNA against FBXO6 were treated with thapsigargin (TG) to trigger ER stress [20] . The apoptosis ratio was determined by both CCK8 and FACS assays. Silencing the expression of FBXO6 promoted cell death under thapsigargin treatment (Fig. 3A-B) . In contrast, overexpression of FBXO6WT but not FBXO6 Mutant promoted cell survival under thapsigargin treatment (Fig. 3C-D) . Thus, these data indicated that FBXO6 controls ER stressinduced apoptosis .
FBXO6 controls ER stress-induced apoptosis via Ero1L degradation
To further investigate the role of FBXO6-mediated Ero1L degradation in ER stressinduced apoptosis, we silenced the expression of Ero1L in FBXO6-depleted A549 cells. We found that A549 cells with FBXO6 and Ero1L double knockdown were less sensitive to ER stress-induced apoptosis (Fig. 4A) . Furthermore, Thapsigargin treatment increased the expression of Ero1L, which was decreased by overexpression of FBXO6WT but not FBXO6 Mutant (Fig. 4B) . Taken together, these data suggest that FBXO6 plays a critical role in inhibiting ER stress-induced apoptosis by targeting Ero1L for destruction. 
Discussion
The identification of ubiquitin E3 ligase substrates has always been difficult, due to the transient interactions, low-affinity, the rapid degradation by 26S proteasome and the poorly defined E3 recognition elements in substrates [21] . As FBXO6 has the ability to recognize and target glycoproteins for destruction, providing us a perfect platform to identify its potential ubiquitination substrates in its interacting glycoproteins. In the present study, we showed that Ero1L is one of the ubiquitin substrates of FBXO6.
Ero1L, a thiol oxidase, is a heavy glycosylated protein. It exists as a collection of oxidized and reduced forms and covalently binds PDI, which catalyzes disulfide formation in newly synthesized proteins entering the mammalian ER [22] . A dynamic equilibrium between Ero1L and glutathione disulfide-mediated oxidation of PDI plays a critical role in ER redox homeostasis and the regulation of Ero1L activity is critical to keep redox homeostasis and proper ER folding activity [23] . Dysfunction of Ero1L leads to a rapid decrease in oxidative protein folding, activation of the UPR, and potential source of ER-derived oxidative stress and might eventually lead to the development of disorders of the nervous system [24] [25] [26] . Thus, the protein level or activity of Ero1L should be tightly regulated. Indeed, our data clearly showed that the stability and ubiquitination were dominated by FBXO6. Overexpression of FBXO6 increased the polyubiquitination and decreased the stability of Ero1L, whereas inhibition of FBXO6 had the opposite effects.
It has been reported that FBXO6 attenuates cadmium toxicity in HEK293 cells by inhibiting ER stress and JNK activation, suggesting FBXO6 might inhibit cadmium-induced ER stress by functioning as a ubiquitin ligase in the ERAD system [18] . In agreement with this, our data showed that silencing the expression of FBXO6 significantly promoted ER stress-induced apoptosis which could be largely abolished by manipulating the protein level of Ero1L. Overexpression of FBXO6WT but not FBXO6Mut significantly inhibited ER stressinduced apoptosis. Thus, our data demonstrate FBXO6 regulates ER stress-induced apoptosis in an Ero1L-dependent manner. Given the critical role of ER stress-induced apoptosis in the development of disorders of the nervous system, our data suggested that FBXO6 could be a potential therapeutic target for those diseases, such as Alzheimer's, Huntington's and Parkinson's disease. 
